Literature DB >> 8317445

Population-based study of survival after osteoporotic fractures.

C Cooper1, E J Atkinson, S J Jacobsen, W M O'Fallon, L J Melton.   

Abstract

Vertebral fractures are the most frequent of the fractures associated with osteoporosis, yet little is known of their impact on health in the United States. To aid in this understanding, the authors examined the survival rate of 335 residents of Rochester, Minnesota, who had an initial radiologic diagnosis of vertebral fracture between 1985 and 1989. Seventy-six died during 809 person-years of follow-up. The overall survival rate was worse than expected, and diverged steadily from expected values throughout the course of the study. At 5 years after diagnosis, the estimated survival was 61% compared with an expected value of 76% (relative survival = 0.81, 95% confidence interval (CI) 0.70-0.92). The 5-year relative survival after a hip fracture in Rochester was a comparable 0.82 (95% CI 0.77-0.87), but there was a much greater excess of deaths within the first 6 months as compared with patients with vertebral fractures. The 5-year relative survival rate after a distal forearm fracture was 1.00 (95% CI 0.95-1.05). Clinically diagnosed vertebral fractures are rarely fatal, and the reduced survival seen subsequently could related to comorbid conditions. Nonetheless, the excess mortality should be accounted for in assessing the public health impact of osteoporosis.

Entities:  

Mesh:

Year:  1993        PMID: 8317445     DOI: 10.1093/oxfordjournals.aje.a116756

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  281 in total

Review 1.  Treatment of postmenopausal osteoporosis: an evidence-based approach.

Authors:  C J Rosen
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  The 2002 Canadian bone densitometry recommendations: take-home messages.

Authors:  Aliya A Khan; Jacques P Brown; David L Kendler; William D Leslie; Brian C Lentle; E Michael Lewiecki; Paul D Miller; R Lawrence Nicholson; Wojciech P Olszynski; Nelson B Watts
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

3.  Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.

Authors:  F Borgström; O Ström; M Kleman; E McCloskey; H Johansson; A Odén; J A Kanis
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

Review 4.  New targets for intervention in the treatment of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Nat Rev Rheumatol       Date:  2011-09-20       Impact factor: 20.543

Review 5.  Arthroplasty options in femoral-neck fracture: answers from the national registries.

Authors:  Arun Kannan; Ramprasad Kancherla; Stephen McMahon; Gabrielle Hawdon; Aditya Soral; Rajesh Malhotra
Journal:  Int Orthop       Date:  2011-09-20       Impact factor: 3.075

6.  Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.

Authors:  Seong-Su Moon; Young-Sil Lee; Sung Woo Kim
Journal:  Endocrine       Date:  2012-03-11       Impact factor: 3.633

7.  Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: a population-based study.

Authors:  N M van Schoor; J H Smit; J W R Twisk; P Lips
Journal:  Osteoporos Int       Date:  2004-10-12       Impact factor: 4.507

Review 8.  Osteoporosis and diabetes.

Authors:  Diane L Chau; Steven V Edelman; Manju Chandran
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

9.  Mortality after osteoporotic fractures.

Authors:  O Johnell; J A Kanis; A Odén; I Sernbo; I Redlund-Johnell; C Petterson; C De Laet; B Jönsson
Journal:  Osteoporos Int       Date:  2003-10-30       Impact factor: 4.507

10.  Excess mortality after hospitalisation for vertebral fracture.

Authors:  John A Kanis; Anders Oden; Olof Johnell; Chris De Laet; Bengt Jonsson
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.